# Studies in Patients With Multiple Myeloma and Renal Failure Due to Myeloma Cast Nephropathy

> **NCT01208818** · PHASE3 · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 284 (estimated)

## Conditions studied

- Chronic Renal Failure With Uremic Nephropathy

## Interventions

- **DRUG:** Cyclophosphamide + Bortezomib + Dexamethasone regimen
- **DRUG:** Bortezomib +Dexamethasone regimen
- **DEVICE:** HCO group
- **DEVICE:** conventional high-flux dialyzer

## Key facts

- **NCT ID:** NCT01208818
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06
- **Primary completion:** 2015-09
- **Final completion:** 2017-12
- **Target enrollment:** 284 (ESTIMATED)
- **Last updated:** 2017-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01208818

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01208818, "Studies in Patients With Multiple Myeloma and Renal Failure Due to Myeloma Cast Nephropathy". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01208818. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*